The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999-2018

被引:1
|
作者
Koohi, Fatemeh [1 ]
Kohansal, Karim [2 ]
Naz, Marzieh Saei Ghare [3 ]
Derakhshan, Somayeh [4 ]
Azizi, Fereidoun [5 ]
Khalili, Davood [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Reprod Endocrinol Res Ctr, Res Inst Endocrine Sci, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Sch Publ Hlth & Safety, Dept Epidemiol, Tehran, Iran
[5] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran
关键词
Cardiovascular risk score; Risk factors; Diabetes; Trend; Cohort study; DISEASE; POPULATION; EPIDEMIOLOGY; COUNTRY; IRAN;
D O I
10.1186/s12889-022-12981-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Assessing the risk of cardiovascular disease (CVD) is crucial in preventive cardiology. We aimed to determine the trend of CVD risk among individuals with and without diabetes during two decades of follow-up in a Middle Eastern cohort. Methods We studied 8,450 individuals (55.5% women) aged 40-75 years who participated in the Tehran Lipid and Glucose Study (TLGS). Diabetes status and CVD risk factors were evaluated in six examinations from 1999 to 2018. The individual 10-year CVD risk score was calculated using the ACC/AHA recommended risk equation. We used generalized estimating equation models (GEE) to assess the time trends of CVD risk factors and CVD risk scores in diabetic and non-diabetic groups separately. Results The age-adjusted ACC/AHA risk score significantly decreased in non-diabetic women and men (from 3.2% to 1.6% in women and 6.8% to 5.0% in men; p for trend < 0.001). Whereas the risk significantly decreased among diabetics men (from 13.8% to 11.5%), it increased somehow among diabetics women (from 5.3% to 5.5%). Furthermore, in both sexes, diabetic individuals compared to non-diabetic ones had better control on their systolic blood pressure, total cholesterol, and fasting plasma glucose during the last two decades. Conclusions The CVD risk and most CVD risk factors improved in individuals with and without diabetes in the past two decades; however, they have not reached the targets yet. So, more stringent lifestyle modifications and treatment strategies are needed, especially for primary prevention in the general population.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Dietary and lifestyle inflammatory scores and risk of incident diabetes: a prospective cohort among participants of Tehran lipid and glucose study
    Farshad Teymoori
    Hossein Farhadnejad
    Ebrahim Mokhtari
    Mohammad Hassan Sohouli
    Nazanin Moslehi
    Parvin Mirmiran
    Fereidoun Azizi
    BMC Public Health, 21
  • [22] Brachial-ankle pulse wave velocity and cardiovascular risk factors in the non-diabetic and newly diagnosed diabetic Chinese: Guangzhou Biobank Cohort Study-CVD
    Xu, Lin
    Jiang, Chao Qiang
    Lam, Tai Hing
    Yue, Xiao Jun
    Cheng, Kar Keung
    Liu, Bin
    Jin, Ya Li
    Zhang, Wei Sen
    Thomas, G. Neil
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (02) : 133 - 139
  • [23] Pulse Pressure and Systolic Blood Pressure are Powerful Independent Predictors of Cardiovascular Disease in Diabetic Adults: Results of an 8.4 years Follow-up of Tehran Lipid and Glucose Study (TLGS)
    Hadaegh, F.
    Hatami, M.
    Sheikholeslami, F.
    Azizi, F.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (09) : 638 - 643
  • [24] Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile
    G Dell'Omo
    G Penno
    S Del Prato
    M Mariani
    R Pedrinelli
    Journal of Human Hypertension, 2009, 23 : 332 - 338
  • [25] Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile
    Dell'Omo, G.
    Penno, G.
    Del Prato, S.
    Mariani, M.
    Pedrinelli, R.
    JOURNAL OF HUMAN HYPERTENSION, 2009, 23 (05) : 332 - 338
  • [26] Triglyceride-Glucose Index as Predictor for Hypertension, CHD and STROKE Risk among Non-Diabetic Patients: A NHANES Cross-Sectional Study 2001-2020
    Sawaf, Bisher
    Swed, Sarya
    Alibrahim, Hidar
    Bohsas, Haidara
    Dave, Tirth
    Nasif, Mohamad Nour
    Hafez, Wael
    Tashrifwala, Fatema Ali Asgar
    Jabban, Yazan Khair Eldien
    Al-Rassas, Safwan
    Saleh, Heba haj
    Zaidi, Abdul Rehman Zia
    Alghalyini, Baraa
    Mohamed, Shaymaa Abdelmaboud
    Mohamed, Waleed Farouk
    Farwati, Amr
    Seijari, Mohammed Najdat
    Battikh, Naim
    Elnagar, Basma
    Iqbal, Seema
    Robles-Velasco, Karla
    Cherrez-Ojeda, Ivan
    JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2024, 14 (03) : 1152 - 1166
  • [27] Trends in predicted 10-year risk for cardiovascular diseases among patients with type 2 diabetes in Thailand, from 2014 to 2018
    Lertsakulbunlue, Sethapong
    Mungthin, Mathirut
    Rangsin, Ram
    Kantiwong, Anupong
    Sakboonyarat, Boonsub
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [28] Impaired glucose tolerance and its co-variates among 2079 non-diabetic elderly subjects - Ten-year mortality and morbidity in the CASTEL study
    Casiglia, E
    Pauletto, P
    Mazza, A
    Ginocchio, G
    diMenza, G
    Pavan, L
    Tramontin, P
    Capuani, M
    Pessina, AC
    ACTA DIABETOLOGICA, 1996, 33 (04) : 284 - 290
  • [29] Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study
    Dehghan, Azizallah
    Jahangiry, Leila
    Khezri, Rozhan
    Jafari, Alireza
    Pezeshki, Babak
    Rezaei, Fatemeh
    Aune, Dagfinn
    BMC ENDOCRINE DISORDERS, 2024, 24 (01)
  • [30] 10-YEAR CARDIOVASCULAR MORTALITY IN RELATION TO RISK-FACTORS AND ABNORMALITIES IN LIPOPROTEIN COMPOSITION IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC AND NONDIABETIC SUBJECTS
    UUSITUPA, MIJ
    NISKANEN, LK
    SIITONEN, O
    VOUTILAINEN, E
    PYORALA, K
    DIABETOLOGIA, 1993, 36 (11) : 1175 - 1184